Rafael Gonzalez-Arroyo

Pozuelo De Alarcon, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Journal: Neurologia

Published: September 27, 2019

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

Journal: Neurologia

Published: September 27, 2019

A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis.

A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis.

Journal: Expert review of neurotherapeutics

Published: September 22, 2018

Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis.

Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: November 26, 2016

Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid.

Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid.

Journal: Clinical neuropharmacology

Published: November 24, 2016

A consensus initiative for the assessment of patients newly diagnosed with multiple sclerosis in Spain: the eXamina Project.

A consensus initiative for the assessment of patients newly diagnosed with multiple sclerosis in Spain: the eXamina Project.

Journal: Neurodegenerative disease management

Published: September 08, 2016

Monoclonal antibodies for the treatment of multiple sclerosis

Monoclonal antibodies for the treatment of multiple sclerosis

Journal: Medicina clinica

Published: March 04, 2015

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).

Journal: Revista de neurologia

Published: October 10, 2014

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)

Journal: Revista de neurologia

Published: September 24, 2014

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).

Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).

Journal: Revista de neurologia

Published: September 06, 2014

Biomarkers in multiple sclerosis: an update for 2014.

Biomarkers in multiple sclerosis: an update for 2014.

Journal: Revista de neurologia

Published: June 11, 2014

Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).

Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).

Journal: Revista de neurologia

Published: September 21, 2013

Showing 1-12 of 18

Last Updated: 09/26/2026